CDC report points finger at Indian firm in Gambia deaths
A probe by the US-based Centres for Disease Control into the deaths of 70 children in Gambia "strongly suggests" cough syrups involving contaminated
Drugs
Medical
Pharma
Drugs
Pharma
FDA rejects Cytokinetics heart disease trial drug
Cytokinetics, a US-based biopharmaceutical company, announced the FDA had rejected its new drug application for approving a trial drug to treat heart problems
Drugs
Health
Pharma
Australian boffins make device to detect cancer from bloodstream
A device, which uses a unique metabolic signature of cancer, differentiates tumor cells from normal blood cells without biopsy, according to Australian researchers.
Drugs
Health
Pharma
Iceland tops list of antidepressant drug users in Europe
Antidepressant drug consumption is on the rise in Europe, and Iceland tops the list, followed by Portugal and the UK, according to the
Drugs
Pharma
FDA nod for Granules India’s drug to treat high blood pressure
Granules India announced the US Food & Drug Administration (US FDA) had approved an Abbreviated New Drug Application (ANDA) for losartan potassium tablets
Drugs
Health
Pharma
Global avian influenza is ‘worrying’: WHO, Cambodia reports girl’s death
The global H5N1 situation is "worrying," and the WHO is investigating reports of death and a confirmed case in a family in Cambodia
Climate
Drugs
Health
Cholera spreads to new geographies in Mozambique
There has been an “exponential” growth in an outbreak of cholera in Mozambique since December, putting pressure on the country’s weak health system,
Climate
Health
US scientists draw up new blueprint for affordable solid-state batteries
Scientists have drawn a blueprint for a solid-state battery which is affordable and good enough to drive a car for miles on a
Drugs
Pharma
FDA closes inspection of Strides Pharma’s Bangalore unit
The USFDA has closed an inspection of India’s Strides Pharma Science in southern Bangalore, which serves markets in the US, Europe and Australia,
Drugs
Pharma
Redx, Jounce to merge in a $425 million all-share deal
Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new